ESC: No Plaque Regression With Aliskiren (CME/CE)

AMSTERDAM (MedPage Today) -- Giving the direct renin inhibitor aliskiren (Tekturna) to patients who have coronary artery disease -- but don't meet clinical criteria for hypertension -- did not slow progression of atherosclerosis, researchers said here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news